Suchergebnisse - "Cervantes, A"

PubPharm (21)

1

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial

enthalten in: ESMO open | 2023

von Dijkstra, E. | Zwart, W. | Nilsson, P. | +18

2

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Bahadoer, R. | Dijkstra, E. | van Etten, B. | +118

CommentIn: Lancet Oncol. 2021 Jan;22(1):2-3. - PMID 33301739

3

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370) : a multicentre, open-label, phase 3, randomised, controlled trial

enthalten in: The Lancet. Oncology | 2019

von Eng, C. | Kim, T. | Bendell, J. | +77

CommentIn: Lancet Oncol. 2019 Jun;20(6):752-753. - PMID 31003912

4

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain : results of a subgroup analysis of the phase 3 RECOURSE trial

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2017

von Longo-Muñoz, F. | Argiles, G. | Tabernero, J. | +8

5

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer : results of the EXPERT-C trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Sclafani, F. | Chau, I. | Cunningham, D. | +16

6

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

enthalten in: British journal of cancer | 2015

von Macarulla, T. | Cervantes, A. | Tabernero, J. | +10

7

Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Peeters, M. | Price, T. | Cervantes, A. | +14

ErratumIn: Ann Oncol. 2014 Mar;25(3):757

8

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Sclafani, F. | Roy, A. | Cunningham, D. | +9

9

Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab : a TTD group cooperative study

enthalten in: PloS one | 2012

von Díaz-Rubio, E. | Gómez-España, A. | Massutí, B. | +71

10

Advanced ovarian cancer : phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel

enthalten in: Journal of the National Cancer Institute | 2010

von Hoskins, P. | Vergote, I. | Cervantes, A. | +20

CommentIn: J Natl Cancer Inst. 2010 Oct 20;102(20):1523-4. - PMID 20937989